Targeted delivery of HER2 siRNA to HER2-overexpressing SKBR3 breast cancer cells has been specific with chitosan/quantum dot nanoparticles surface labeled with HER2 antibody targeting the HER2 receptors on SKBR3 cells [18]. Here, ERBB2 is linked to breast cancer.